Róbert Wessman, Alvogen CEO
Biotech billionaire Róbert Wessman engineers $450M deal for Alvogen subsidiaries
Alvogen is handing off two of its subsidiaries to CEO Róbert Wessman and his healthcare investment firm Aztiq — who has now tied the two together …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
